Murine models of COPD
- PMID: 16084119
- DOI: 10.1016/j.pupt.2005.06.001
Murine models of COPD
Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation, that is not fully reversible, and that is associated with an abnormal inflammatory response of the airways and lungs to noxious particles and gases. The airflow limitation is caused by increased resistance of the small conducting airways and by decreased elastic recoil forces of the lung due to emphysematous destruction of the lung parenchyma. In vivo animal models can help to unravel the molecular and cellular mechanisms underlying the pathogenesis of COPD. Mice represent the most favored animal species with regard to the study of (both innate and adaptive) immune mechanisms, since they offer the opportunity to manipulate gene expression. Several experimental approaches are applied in order to mimic the different traits of COPD in these murine models. Firstly, the tracheal instillation of tissue-degrading enzymes induces emphysema-like lesions in the lung parenchyma, adding further proof to the protease-antiprotease imbalance hypothesis. Secondly, the inhalation of noxious stimuli, including tobacco smoke, sulfur dioxide, nitrogen dioxide, or oxidants such as ozone, may also lead to COPD-like lesions in mice, depending on concentration, duration of exposure and strainspecific genetic susceptibility. Thirdly, in transgenic mice, a specific gene is either overexpressed (non-specific or organ-specific) or selectively depleted (constitutively or conditionally). The study of these transgenic mice, either per se or in combination with the above mentioned experimental approaches (e.g. the inhalation of tobacco smoke), can offer valuable information on both the physiological function of the gene of interest as well as the pathophysiological mechanisms of diseases with complex traits such as COPD.
Similar articles
-
NO2-induced airway inflammation is associated with progressive airflow limitation and development of emphysema-like lesions in C57bl/6 mice.Exp Toxicol Pathol. 2005 Apr;56(6):341-50. doi: 10.1016/j.etp.2004.12.004. Exp Toxicol Pathol. 2005. PMID: 15945273
-
Models of chronic obstructive pulmonary disease.Respir Res. 2004 Nov 2;5(1):18. doi: 10.1186/1465-9921-5-18. Respir Res. 2004. PMID: 15522115 Free PMC article. Review.
-
Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma.Rom J Morphol Embryol. 2008;49(4):495-505. Rom J Morphol Embryol. 2008. PMID: 19050798
-
Lung structure and function in COPD.Int J Tuberc Lung Dis. 2008 May;12(5):467-79. Int J Tuberc Lung Dis. 2008. PMID: 18419881 Review.
-
Pathogenesis of COPD.Semin Respir Crit Care Med. 2005 Apr;26(2):142-53. doi: 10.1055/s-2005-869535. Semin Respir Crit Care Med. 2005. PMID: 16088433 Review.
Cited by
-
Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig.Respir Res. 2009 Aug 14;10(1):76. doi: 10.1186/1465-9921-10-76. Respir Res. 2009. PMID: 19682386 Free PMC article.
-
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Pharmacol Rev. 2010 Dec;62(4):726-59. doi: 10.1124/pr.110.002733. Pharmacol Rev. 2010. PMID: 21079042 Free PMC article. Review.
-
Monitoring in vivo changes in lung microstructure with ³He MRI in Sendai virus-infected mice.J Appl Physiol (1985). 2012 May;112(9):1593-9. doi: 10.1152/japplphysiol.01165.2011. Epub 2012 Mar 1. J Appl Physiol (1985). 2012. PMID: 22383505 Free PMC article.
-
Effects of Ergosterol on COPD in Mice via JAK3/STAT3/NF-κB Pathway.Inflammation. 2017 Jun;40(3):884-893. doi: 10.1007/s10753-017-0533-5. Inflammation. 2017. PMID: 28251448
-
Impact of the loss of Hoxa5 function on lung alveogenesis.Am J Pathol. 2006 Oct;169(4):1312-27. doi: 10.2353/ajpath.2006.051333. Am J Pathol. 2006. PMID: 17003488 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical